Capstone Expands Commercial Market Reach with KLAD Integration, Unlocking High-Margin, Asset-Light Revenue Growth

Go back to Capstone Expands Commercial Market Reach with KLAD Integration, Unlocking High-Margin, Asset-Light Revenue Growth
Capstone Therapeutics Corp (NASDAQ: CAPS) Delayed: 0.27 -0.01 (3.57%)
Previous Close $0.28    52 Week High $0.15 
Open $0.29    52 Week Low $0.04 
Day High $0.29    P/E N/A 
Day Low $0.27    EPS $-0.27 
Volume 169,193